肺开放、机器人与胸腔镜肺叶切除术研究:微创肺叶切除术中中转开胸的结局与危险因素
该倾向匹配队列研究基于21家机构2011至2019年连续肺叶切除术病例,分析临床IA至IIIA期肺癌微创肺叶切除术中中转开胸的结局与危险因素。机器人肺叶切除术中转率低于胸腔镜肺叶切除术(3.6% vs 12.9%;P < .0001)。中转微创肺叶切除术的围手术期死亡率与开放肺叶切除术相比无更差。
要点
- 机器人肺叶切除术中转率低于胸腔镜肺叶切除术(3.6% vs 12.9%;P < .0001)。
- 肿瘤大小和新辅助治疗是中转开胸最显著的危险因素,其次为既往心脏手术、充血性心力衰竭、慢性阻塞性肺疾病、胸腔镜入路、男性、体重指数和第一秒用力呼气容积。
- 机器人肺叶切除术血管原因中转多于胸腔镜(24.8% vs 14%;P = .01),解剖原因中转少于胸腔镜(45.6% vs 66.6%;P = .0002)。
核心结论
- 中转微创肺叶切除术的围手术期死亡率与开放肺叶切除术相比无更差。
- 与胸腔镜肺叶切除术相比,机器人肺叶切除术在此倾向评分匹配队列中与较低的中转概率相关。
研究设计与样本
- 研究为倾向匹配队列研究,数据来自肺开放、机器人与胸腔镜肺叶切除术研究联盟的21家机构,回顾性收集2011至2019年连续因临床IA至IIIA期肺癌行肺叶切除术的病例。
- 采用逆概率治疗加权倾向评分法平衡各手术方式的基线特征,使用单因素逻辑回归检验中转危险因素,并采用逐步模型选择法进行多因素逻辑回归分析。
主要发现
- 机器人肺叶切除术中转率低于胸腔镜肺叶切除术(3.6% vs 12.9%;P < .0001)。
- 多因素回归模型中,肿瘤大小和新辅助治疗是最显著的中转危险因素,其次为既往心脏手术、充血性心力衰竭、慢性阻塞性肺疾病、胸腔镜入路、男性、体重指数和第一秒用力呼气容积。
- 解剖原因中转在胸腔镜肺叶切除术中比机器人肺叶切除术更常见(66.6% vs 45.6%;P = .0002);血管原因中转在机器人肺叶切除术中比胸腔镜肺叶切除术更常见(24.8% vs 14%;P = .01)。
- 急诊中转率在机器人肺叶切除术与胸腔镜肺叶切除术之间相当(0.5% vs 0.7%;P = .25),无术中死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Conversion to thoracotomy continues to be a concern during minimally invasive lobectomy. The aim of this propensity-matched cohort study is to analyze the outcomes and risk factors of intraoperative conversion during video-assisted thoracoscopic surgery (VATS) and robotic lobectomy (RL). METHODS: Data from consecutive lobectomy cases performed for clinical stage IA to IIIA lung cancer was retrospectively collected from the Pulmonary Open, Robotic, and Thoracoscopic Lobectomy study consortium of 21 institutions from 2011 to 2019. The propensity-score method of inverse-probability of treatment weighting was used to balance the baseline characteristics across surgical approaches. Univariate logistic regression models were applied to test risk factors for conversion. Multivariable logistic regression analysis was conducted using a stepwise model selection method. RESULTS: Seven thousand two hundred sixteen patients undergoing lobectomy were identified: RL (n = 2968), VATS (n = 2831), and open lobectomy (n = 1417). RL had lower conversion rate compared with VATS (3.6% vs 12.9%; P < .0001). In the multivariable regression model, tumor size and neoadjuvant therapy were the most significant risk factors for conversion, followed by prior cardiac surgery, congestive heart failure, chronic obstructive pulmonary disease, VATS approach, male gender, body mass index, and forced expiratory volume in 1 minute. Conversions for anatomical reasons were more common in VATS than RL (66.6% vs 45.6%; P = .0002); however, conversions for vascular reasons were more common in RL than VATS (24.8% vs 14%; P = .01). The rate of emergency conversions was comparable between RL and VATS (0.5% vs 0.7%; P = .25) with no intraoperative mortalities. CONCLUSIONS: Converted minimally invasive lobectomies were not associated with worse perioperative mortality compared with open lobectomy. Compared with VATS lobectomy, RL is associated with a lower probability of conversion in this propensity-score matched cohort study.
引用
- Herrera LJ, Schumacher LY, Hartwig MG, et al. Pulmonary Open, Robotic, and Thoracoscopic Lobectomy study: Outcomes and risk factors of conversion during minimally invasive lobectomy. J Thorac Cardiovasc Surg. 2022. PMID: 36509569. doi:10.1016/j.jtcvs.2022.10.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。